A diagnosis of mesothelioma is life-changing, but advancements in treatment and medical research offer new possibilities for extending survival.
These mesothelioma treatments can also improve the quality of life and reduce symptoms.
Free Case Review
Malignant mesothelioma is an aggressive, rare cancer that develops in the mesothelium.
The mesothelium is a thin layer of tissue covering various internal organs.
Its development is most commonly linked to asbestos exposure, with symptoms often appearing decades after initial exposure.
There are four main mesothelioma types, classified based on where the cancer develops:
Pleural mesothelioma is the most common type, affecting the lung lining (pleura). It accounts for approximately 80-90% of cases and causes signs and symptoms like chronic cough, chest pain, and difficulty breathing. These can be similar to lung cancer, so proper diagnosis is critical.
Peritoneal Mesothelioma is the second most common form of mesothelioma. It’s in the abdominal lining (peritoneum) and is the second most common form. Symptoms may include abdominal pain, bloating, and digestive issues.
Pericardial mesothelioma is a rare form of cancer that affects the heart lining (pericardium). It often causes chest pain, irregular heartbeat, and breathing difficulties.
Testicular mesothelioma is the rarest form. It develops in the lining of the testes (tunica vaginalis) and sometimes presents as a lump or swelling in the scrotum.
Exposure to asbestos fibers is the primary known cause of mesothelioma.
When asbestos-containing materials are disturbed, microscopic fibers become airborne and can be inhaled or ingested.
Over time, these fibers become trapped in the mesothelium, causing chronic inflammation, scarring, and eventually, cancer mutations.
Asbestos exposure is most common in high-risk industries, including:
Construction and demolition
Shipbuilding and military service
Manufacturing and industrial work
Firefighting and first responder occupations
While asbestos exposure is the main cause, other factors may elevate the risk of developing mesothelioma, including:
Genetic Predisposition—Some individuals inherit mutations, such as the BAP1 gene mutation, which may increase their susceptibility to mesothelioma.
Radiation Exposure – In rare cases, individuals who have undergone radiation therapy to their chest or abdomen for other cancers may have a higher risk of developing mesothelioma.
Since mesothelioma often develops decades after exposure, individuals with a history of asbestos exposure should monitor for symptoms and seek early medical evaluation if concerns arise.
Treatment for malignant mesothelioma depends on factors such as the cancer stage, the particular type of mesothelioma, the cell type, and the patient’s overall health.
While there is no cure, a combination of surgery, chemotherapy, and radiation can help with managing symptoms, slow the tumor’s progression, and improve quality of life.
For patients diagnosed in the early stages, surgery may be an option to remove tumors and affected tissue.
The goal is to remove all the cancer or as much as possible while preserving lung and organ function when feasible.
This type of treatment may not be an option to treat mesothelioma when the cancer has spread and is more difficult to treat.
A radical surgery performed on patients with pleural mesothelioma.
Involves the removal of an entire lung, the pleura (lung lining), diaphragm, and pericardium (heart lining).
Typically performed in early-stage patients who are otherwise healthy enough to withstand lung removal.
Though aggressive, it may improve survival when combined with chemotherapy or radiation.
A lung-sparing alternative to EPP, removing only the pleura and visible tumors while preserving the lung.
Often recommended for pleural mesothelioma patients who are not candidates for EPP.
It may be combined with chemotherapy or radiation for better outcomes
Used primarily for peritoneal mesothelioma (which affects the abdominal lining).
Aims to remove as much of the cancerous tissue as possible from the abdominal cavity.
Often combined with intraperitoneal chemotherapy (HIPEC) to kill remaining cancer cells.
Chemotherapy is the most widely used treatment for mesothelioma, especially for patients who cannot undergo surgery as part of their cancer care.
It helps slow tumor growth, shrink tumors before surgery, or kill cancer cells remaining after surgery
Pemetrexed (Alimta) combined with cisplatin is the standard first-line chemotherapy for mesothelioma.
Administered intravenously, meaning it travels through the bloodstream to reach cancer cells throughout the body.
Side effects can include nausea, fatigue, and lowered immune function, but newer medications help manage these effects
Used specifically for peritoneal mesothelioma.
Involves heating chemotherapy drugs and then delivering them directly in the abdominal cavity after cytoreductive surgery.
The heat enhances the drug’s effectiveness while reducing systemic side effects.
Radiation therapy can shrink tumors, relieve symptoms, and prevent recurrence after surgery. It is most effective when combined with other treatments in a multimodal approach
The most common form of radiation therapy delivers high-energy beams to tumors while sparing healthy tissue.
Helps reduce pain and breathing difficulties in pleural mesothelioma patients.
A more advanced form of radiation with the adjusted intensity of beams for precise targeting.
Reduces damage to surrounding organs and tissues while increasing the effectiveness against tumors.
Multimodal therapy combines surgery, chemotherapy, and radiation therapy for a comprehensive approach.
Patients who qualify for aggressive multimodal treatment often experience better survival rates than those receiving a single treatment.
Emerging treatments such as immunotherapy and targeted therapies are now being integrated into multimodal treatment plans to further improve outcomes
Because each mesothelioma case is unique, treatment plans should be developed by a specialized team of oncologists, surgeons, and radiation specialists.
As research continues to advance in the field of mesothelioma treatment, many patients also explore clinical trials and experimental therapies.
As research advances, new and emerging treatments for mesothelioma are providing hope for extended survival and improved quality of life.
These therapies go beyond traditional surgery, chemotherapy, and radiation, targeting cancer at the molecular and cellular level to enhance treatment effectiveness.
While many of these treatments are still in clinical trials, they represent promising developments in mesothelioma care.
Immunotherapy for mesothelioma stimulates the body’s natural defenses to recognize and destroy cancer cells.
Since mesothelioma is known to evade the immune system, these relatively new treatments help patients mount a stronger immune response.
Drugs like pembrolizumab (Keytruda) and nivolumab (Opdivo) help the immune system recognize mesothelioma cells as threats.
These inhibitors block proteins like PD-1 and CTLA-4, which tumors use to hide from the immune system.
Some patients respond well to checkpoint inhibitors, particularly when combined with other treatments like chemotherapy.
This cutting-edge therapy involves genetically modifying a patient’s T-cells to attack mesothelioma cells.
The engineered T-cells are then infused back into the patient’s body. Once there, they can seek out and destroy cancer cells.
CAR T-cell therapy is currently being researched in clinical trials but has shown promise in treating other aggressive cancers.
Unlike traditional chemotherapy, targeted therapy focuses on specific genetic and molecular changes within mesothelioma cells, minimizing damage to healthy tissue.
Alters or replaces defective genes that contribute to cancer growth.
Some experimental approaches introduce genetic material into mesothelioma cells, making them more susceptible to other treatments like chemotherapy or immunotherapy.
Gene therapy is still in the early stages of development but may become a key component of future mesothelioma treatment.
These drugs block new blood vessel formation (angiogenesis) that tumors need to grow.
Without an adequate blood supply, tumors are unable to spread as quickly.
Bevacizumab (Avastin) is an example of an angiogenesis inhibitor that has been tested for mesothelioma treatment.
Photodynamic therapy (PDT) is a noninvasive treatment that uses light-sensitive drugs and lasers to target tumors. It is being studied as an approach to treating malignant mesothelioma.
A light-sensitive drug (photosensitizer) is administered and absorbed by cancer cells.
After some time, a laser is directed at the tumor, activating the drug.
The activated drug produces a reaction that destroys cancer cells.
PDT has been used in some pleural mesothelioma patients to help remove microscopic cancer cells after surgery.
Researchers are exploring ways to combine PDT with immunotherapy and chemotherapy for greater effectiveness.
While these emerging treatments are still being tested, they offer hope for longer survival and better quality of life for mesothelioma patients.
Many of these therapies are available through clinical trials, which give patients access to advanced treatments that may not yet be widely available.
As research continues, the future of mesothelioma care will likely involve combinations of these innovative approaches to improve patient outcomes.
Choosing the right treatment for mesothelioma is a complex process dependent on several key factors.
Because mesothelioma is a rare and often aggressive form of cancer, treatment plans must be personalized based on the patient’s stage of diagnosis, overall health, and personal preferences.
It’s also dependent on the location of the cancer.
For example, someone with pleural mesothelioma might have different treatment options than someone with peritoneal mesothelioma.
While some patients may pursue aggressive treatments to extend survival, others may prioritize quality of life and symptom management rather than taking a conventional approach to the treatment of mesothelioma.
The stage of mesothelioma at diagnosis plays a critical role in determining which treatments are available and how effective they may be.
Patients diagnosed in earlier stages are more likely to be candidates for surgery, as the cancer is still localized.
Multimodal treatment, which combines surgery, chemotherapy, and radiation, may offer the best chance for extending survival.
Some patients may also qualify for emerging therapies or clinical trials.
Once mesothelioma has spread to distant organs or the lymphatic system, surgery is often no longer an option.
Treatments focus on slowing cancer progression and managing symptoms.
Chemotherapy, immunotherapy, and radiation therapy can help relieve pain and improve breathing difficulties.
Palliative care becomes a crucial part of treatment, focusing on maintaining comfort and quality of life.
Each patient’s overall health and existing medical conditions influence the ability to tolerate aggressive treatments like surgery or chemotherapy.
Patients in good physical condition with no major underlying conditions are more likely to be eligible for surgery and intensive treatments.
Those with heart disease, lung disease, or other serious illnesses may not tolerate aggressive treatments and may benefit more from palliative-focused care.
For some patients, prolonging life may not be the only priority—minimizing side effects and maintaining independence may be more important.
Chemotherapy and radiation can cause significant side effects like nausea, fatigue, and immune suppression.
Some patients choose less aggressive treatment plans to maintain their day-to-day well-being.
Pain management, respiratory therapies, and supportive care can help improve comfort without invasive procedures.
Each mesothelioma case is unique, and treatment decisions should be made in collaboration with a mesothelioma specialist.
By considering the stage of the disease, overall health, and personal goals, patients can choose the path that aligns with their individual needs and values.
Clinical trials play a vital role in advancing mesothelioma treatment by testing new therapies, improving existing treatments, and providing patients with access to cutting-edge options that may not yet be widely available.
For many mesothelioma patients, participating in a clinical trial offers hope for extended survival and improved quality of life while also contributing to research that can benefit future patients.
Clinical trials allow patients to try innovative therapies before they become standard treatment options.
Many trials focus on emerging treatments, such as immunotherapy, gene therapy, and targeted therapies, which may improve the outcomes of certain patients.
Trials also test new drug combinations and approaches to multimodal therapy, aiming to enhance effectiveness while reducing side effects.
Some trials focus on genetic profiling, allowing doctors to match patients with treatments tailored to their tumor’s genetic makeup.
Patients who have exhausted standard treatment options may find clinical trials as a viable alternative.
Several organizations and databases provide updated listings of active mesothelioma clinical trials, including:
ClinicalTrials.gov – A government-run database listing mesothelioma trials worldwide.
National Cancer Institute (NCI) – It offers a searchable database of ongoing cancer trials.
Mesothelioma Research Organizations – Groups like the Mesothelioma Applied Research Foundation (MARF) can help connect patients with suitable trials.
Since eligibility for clinical trials varies, consulting a mesothelioma specialist can help patients determine which trials match their diagnosis and treatment history. Enrolling in a clinical trial can provide people with cancer access to promising new therapies while also advancing research that may benefit future mesothelioma patients.
Palliative care plays a crucial role in improving the quality of life for mesothelioma patients by managing symptoms and providing both emotional and physical support.
Unlike curative treatments, palliative care focuses on relieving pain, easing breathing difficulties, and enhancing overall comfort at any stage of the disease.
It can be integrated alongside other treatments like chemotherapy, radiation, or immunotherapy to help minimize side effects.
Palliative care is designed to help patients feel as comfortable as possible, regardless of their treatment plan or disease stage.
It can reduce symptoms and provide relief from pain, shortness of breath, fatigue, nausea, and anxiety, which are common in mesothelioma patients.
Patients receiving palliative care often experience less distress and better emotional well-being, allowing them to focus on spending time with loved ones.
Doctors, nurses, and palliative care specialists work as a team to address the physical, emotional, and psychological challenges of mesothelioma.
Depending on the patient’s needs, palliative care can be provided at home, in outpatient clinics, or within a hospital.
Pain is common among mesothelioma symptoms, particularly in advanced stages.
Effective pain management may involve:
Opioid medications like morphine or fentanyl are used to relieve severe pain.
Nerve blocks to target localized pain in affected areas.
Integrative therapies, such as acupuncture or relaxation techniques, can complement medication.
Since mesothelioma often affects lung function, breathing difficulties can become a major concern.
Palliative care offers several interventions to help. These include:
Oxygen therapy to improve oxygen levels and ease shortness of breath.
Thoracentesis or pleurodesis to drain excess fluid buildup (pleural effusion) around the lungs.
Pulmonary rehabilitation, with breathing exercises and physical therapy to strengthen the function of the lungs.
.
Palliative care also includes emotional and psychological support, helping both patients and their loved ones cope with the challenges of mesothelioma.
Accessing palliative care early in the treatment process can significantly enhance comfort and improve overall well-being.
A mesothelioma diagnosis affects not only the patient but also their loved ones.
Accessing support resources can help individuals navigate the emotional, financial, and legal challenges associated with this disease.
These resources can provide essential guidance and relief, from connecting with other people facing similar struggles to securing economic assistance.
Finding a supportive community can significantly improve the quality of life for both patients and caregivers.
Mesothelioma support groups offer a space to share experiences, receive encouragement, and gain practical advice on managing the disease.
Emotional Support: Speaking with others who understand the challenges of mesothelioma can help reduce feelings of isolation.
Access to Information: Support groups often feature discussions led by medical professionals, legal experts, and patient advocates who provide valuable insights.
Online and In-Person Options: Patients can connect with groups through local hospitals, cancer centers, or online communities such as those hosted by the Mesothelioma Applied Research Foundation (MARF) or the Asbestos Disease Awareness Organization (ADAO)
The high cost of mesothelioma treatment can be overwhelming, but financial and legal resources are available to help patients manage expenses and secure compensation
It depends on the type, stage, and patient health; it is often a combination of therapies.
Currently, there is no cure, but treatments can extend life expectancy and improve the quality of life.
Research studies test new treatments, and participation may provide access to innovative therapies. What’s tested in clinical trials often becomes a standard part of treatment.
Common side effects of chemo, a common treatment for mesothelioma, include nausea, fatigue, and hair loss; these vary by individual and the specific drugs used.
It has shown promise in clinical trials, but its effectiveness varies by individual case for people with pleural mesothelioma and other types of mesothelioma.
If you or someone you know has been diagnosed with mesothelioma due to asbestos exposure, don’t wait to take legal action. Our experienced attorneys are here to help you navigate the legal process, fight for your rights, and secure the compensation you deserve.
We work on a contingency fee basis, meaning you have no upfront costs that come with your mesothelioma claims.
We don’t get paid unless we win your case and receive compensation.
Fill out the form below and get your free case review